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INTRODUCTION

The etiology of human rheumatoid arthritis has remained
obscure in spite of years of attempts to isolate a causative agent.
However, experimental production of arthritis in rats or mice has been
demonstrated to be a useful model in elucidating immunological and
histopathological characteristics of the disease.

The synovitis,

periarthritis, and chronic nature of the disease suggest certain simi
larities to human rheumatoid arthritis.
Although a variety of etiologic agents can produce joint
inflammation, recent interest has focused on disease in rodents induced
by Mycoplasma arthritidis.

The type of pathogenesis produced by

infectious agents in a variety of disease states has been shown to be
dependent upon the immune responses of the host as well as upon the
nature of the etiologic agent.

In particular, virulence of organisms,

numbers of organisms, and portal of entry influence development and
course of infections.

Both past exposure to an infectious agent and the

integrity of immune mechanisms are responsible for resistance of the
host.

However, the extent to which each factor contributes to the

pathogenesis in Mycoplasma-induced arthritis remains an enigma.
Rats infected with M_. arthritidis fail to produce metabolisminhibiting (MI) antibodies against the mycoplasmal organism.
1

Interest

2

in MI antibodies stems largely from the relationship between such
antibodies and resistance to both experimentally induced and naturally
acquired disease caused by Mycoplasma pneumoniae. Presumably7
lack of MI antibody production could permit M_. arthritidis to establish
itself in joints and promote the inflammatory response typical of joint
disease.
The lack of a cell wall in mycoplasmas makes their membranes
amenable to alteration by constituents of culture media.

The effect of

such physicochemical alterations on antigenic or arthritogenic properties
of M_. arthritidis, however, has not been established.

It appears

likely that biologic components of mycoplasmal membranes could also
affect immune responses to other antigens in animals other than rodent
hosts.

Mycoplasmas are ubiquitous in nature and frequently isolated

from a variety of host cells in the absence of symptoms of infectious
disease.

REVIEW OF THE LITERATURE

A strain of Mycoplasma was first reported to be the etiologic
agent of rat polyarthritis by Klieneberger in 1939. An earlier report
postulated that a pyogenic filterable agent from a sarcoma of an albino
rat caused hind limb paralysis in rats (Woglam and Warren, 1938).
This filterable agent could well have been a mycoplasmal organism.
Spontaneous infectious arthritis appears rather frequently in both rat
and mouse colonies.

In most cases of natural infections only minimal

immune responses have been reported (Lynn, 1967).

Macroscopic

joint lesions, disfigurement, and immobility of joints are remarkably
similar to pathognomy associated with human rheumatoid arthritis (Cole
et al • / 1971b).
Preston (194 2) isolated a pleuropneumonia-like organism from
the knee joint of a rat used in hormone studies.

Upon subsequent

inoculation into uninfected rats, the organism produced lesions resem
bling those of pyogenic infections rather than rheumatoid arthritis.
The severity of histopathological changes increased with repeated
passage in animals.

The ability to cause disease disappeared with

further subculture in vitro.

Howell and Jones (1963) demonstrated that

pathogenic mycoplasmal organisms obtained from the Murphy Sturm
lymphosarcoma lost the capacity to produce arthritis in rats when the
3

4
organism was subcultured in Difco PPLO broth.

Pathogenicity was

restored when the organism was grown either in a sterile, cell-free
extract of tumor tissue in vitro or in tumor tissue in vivo. Apparently,
the tumor tissue was supplying some nutrient factors necessary for the
organism to become established in the host.
Sabin (1939), using Sabin type B strain and a serologically
related strain of a pleuropneumonia-like organism isolated from rat
lung, produced disease in mice which resembled more closely the
histopathology of human rheumatoid arthritis.

Pathological changes

occurred in the capsule, synovia, cartilage, and subchondral bone
marrow, but actual destruction of the cartilage was not observed until
the fourth week (Sabin, 1940).
Repeated reports have appeared concerning the isolation of
mycoplasmal organisms from joint fluids and tissues of patients with
rheumatoid arthritis (Butas, 1957; Jonsson, 1961; Bartholomew, 1965,
1967; Jansson and Wager, 1967; Williams, Brostoff, and Roitt, 1970).
Some caution, however, must be exercised in suggesting that mere
presence of the organisms involves them in the pathogenesis of disease.
None of the studies has convincingly excluded the possibility of acci
dental tissue contamination.
Although it is not certain that mycoplasmas are directly
involved in human rheumatoid disease, the fact that joint disease can

5

be induced by M_. arthritidis in rodents has made the mycoplasmainfected rodent a popular model for studying immunological and
histopathological characteristics of joint disease (Klieneberger-Nobel,
1960; Lemcke, 1961; Cole et al • / 1969a; Golightly-Rowland et al • / 1970;
Cole et al • / 1971a, b).

Cole et al. (1969) showed that rats injected iv

with high doses of M_. arthritidis developed chronic arthritis and pro
duced high titers of complement-fixing (CF) antibodies, but that CF
antibodies had no role in subsequent resistance of animals to arthritis.
CF antibody titers rose rapidly and were sometimes present before
symptoms of disease appeared.

The early increase in CF antibody is

suggestive of a secondary antibody response.

Because rats frequently

harbor M_. arthritidis, infecting doses of the organism could have
stimulated a secondary response.
More recent interest in animal models for Mycoplasma-induced
arthritis has stressed not only immunological responses, but also hostparasite relationships in which the disease can be consistently
reproduced.

Determination of ED^q of a variety of strains of

M. arthritidis disclosed a large diversity in the arthritogenic properties
(Golightly-Rowland et al. , 1970).

The dose of organisms which caused

arthritis in 5 0% of the animals was considered to be the ED^q.
Generally, ED5Q values were lower after passage in rats, and more
severe arthritis with a shorter period of onset was observed.

6

The more arthritogenic strains grew more slowly on artificial culture
medium, but remained viable for longer periods of time. Various strains
appeared to be identical in their ability to stimulate production of CF
antibodies.
MI antibody techniques have been employed for the past several
years to detect the presence of antibodies to mycoplasmal species which
interfere with metabolism of specific substrates such as glucose or
arginine.

Studies by Purcell et al. (1969) indicate that growth-inhibiting

(GI) and MI antibodies may be either closely related or identical.

MI

antibodies in serum have been demonstrated to correlate directly with
resistance to both experimentally induced and naturally acquired
disease involving M_. pneumoniae (Smith et al • / 1967; Chanock et al. ,
1967).

Cole et al. (1970) showed a positive correlation between the

ability of M_. pulmonis and M. neurolyticum to cause disease and the
impairment of MI response in natural hosts.
Experimentally induced arthritis in rats using M_. arthritidis
has, likewise, been characterized by the inability to demonstrate MI
antibodies. Cole et al. (1969) found that rats possessed the ability to
produce MI antibodies against the following non-murine Mycoplasma
species; M_. bovigenitalium, M. felis, M. hyrorrhinis , M. hominis,
M. gallinarium, and M_. masculosum.

Further studies indicated that the

presence of a heterogenetic antigen common to membranes of M_.

7

arthritidis and rat tissue may explain the lack of MI antibody production
(Cahill et al. , 1971).

However, the chemical nature of the antigen

promoting this biologic mimicry has not been identified.
Because the exact nutritional requirements for strains of M.
arthritidis have yet to be established, culture media are commonly enriched
with yeast extract and animal serum. Most strains grow well using yeast
extract in concentrations of 5 to 10% and animal serum in concentrations of
10 to 20%. Williams et al. (1970) demonstrated that hi. fermentans_ mem
branes can firmly bind immunoglobulins from media containing human.
horse, calf, pig, or goat serum. The propensity of M_. fermentans to incor
porate globulins from the growth medium in the membrane and the occurrence
of that organism in 31 of 70 specimens of synovial fluid from patients
with rheumatoid arthritis led those investigators to postulate a role for
the mycoplasmal organism in the disease.

Membrane-associated

globulins could explain the antibodies against slightly altered homologous
gamma globulin frequently detected in serum of rheumatoid patients
(Hong and West, 1964; Claman and Merrill, 1966; Clausen, Raashow,
and Sorenson, 1968).

In primary atypical pneumonia caused by

M. pneumoniae, the known incidence of peculair immunological
reactions including the cold agglutinin phenomenon (Peterson, Ham, and
Finland, 1943) and the presence of CF antibodies for lung antigens
(Thomas et al. , 1943), raises the possibility that other mycoplasmas
may be proper candidates for etiologic roles in auto-immune disease.

8

Regulation of fatty acid supplied in the culture medium influ
enced membrane content of the saprophyte, M_. laidlawii (Razin et al • /
1966). A change in ratio of saturated fatty acids in favor of the
unsaturated fatty acids was associated with a greater cell yield and
osmotic stability.

C-*-^ of labeled oleic, palmitic, and stearic acids

added to the growth medium was incorporated mostly into the phospho
lipid fraction of membrane lipids.

Oleic acid, in particular, improved

growth and resistance of the organism to osmotic lysis.
Variation in fatty acid content of growth media can also produce
characteristic morphological changes.

McElhaney and Tourtellotte

(1969) showed that cells grown in the presence of palmitic or stearic
acids existed mostly as spheres and short filaments, whereas cells
grown in oleic, dihydrosterculic, or isopalmitic acids exhibited long,
fine filamentous forms.

Mycoplasmas cultured in stearic acid were

reported to eventually undergo swelling and lysis.

The effect of similar

alterations in growth medium on antigenic properties or virulence of
mycoplasmas appears not to have been studied.
Although there is a rapidly expanding amount of information
about host-immune responses toMycoplasma species, there appears to
be little information about the possible effect of these organisms on the
immune responses of infected hosts to other stimuli.

Furthermore, there

seems to be no information on immune responses to other stimuli in the

9
presence of mycoplasmas in animals other than rodent hosts.

It has

long been recognized that responses to specific antigens are conditioned
by prior or concurrent exposure to antigenic stimulation or immunosup
pression.

Michaelis (1904) demonstrated that albumin fractions of

horse or cattle serum elicited a large precipitin reaction in rabbits, but
that injection of whole serum resulted in precipitin formation only against
the globulin fraction of serum.

The phenomenon was termed "Konkurrenz

de Antigene" by Michaelis. Abramoff and Wolfe (1956) showed chickens
made substantially lesser amounts of antibody to bovine serum albumin
if injected simultaneously with human gamma globulin.
Adler (1957) demonstrated that when guinea pigs were immunized
with mixtures of rabbit globulin and hemocyanin, the degree of interfer
ence with antibody formation against golbulin was roughly proportional
to the antibody response to hemocyanin.

Nossal and Lederberg (1958)

and Nossal (1958, 1960) studied in vitro production of antibodies by
single cells from rats immunized with two Salmonella serotypes at the
same time and found cells producing one type of anti-flagellin only.
Biozzi, Halpern, and Binaghi (1959) demonstrated that, in passive
cutaneous anaphylaxis, fixation of antigens by cells depended on
physicochemical properties of molecules.

Serum globulin molecules of

similar size from rabbits, guinea pigs, rats, pigs, or humans had
different affinities for cells.

Those investigators suggested that the

10
affinities of the antibody-producing cells for antigens parallel the
abilities of antigens to act as effective competitors.

The exact

mechanism of competitive inhibition, however, or the stage at which
interference may occur is not well understood.
Another type of suppression of the immune response by
materials associated with antigens has been described in the past few
years. Alpha protein, lipopolysaccharide, endotoxin and its lipoid A
component, cardiolipin, normal serum, and chlorphenesin
(3-p-chlorophenoxy-l, 2-propanediol) inhibited formation of antibody to
common Gram negative or Gram positive antigen (Mowbray, 1936;
Suzuki et al. , 1964; Whang and Neter, 1967, 1968, 1970). The suppres
sion of antibody production appeared to be dependent on incubation of
those materials with antigen prior to immunization.
An antigen common to many Gram negative enteric bacilli
which reacted with Escherichia coli (014) antiserum was first reported
by Kunin, Beard, and Halmagyi (1962). Although Enterobacter, Salmonella,
Shigella, Proteus, and other strains of Escherichia species all contained
common antigen (CA), only E. coli (014) elicited production of high titers
of antibodies against CA.

The lack of immunogenicity could be explained

by neither lesser amounts of the antigen nor by its absence from the cell
surface (Neter et al • / 1964; Aoki, Merkel, and McCabe, 1966).

CA

specific antibodies could be produced if the supernates from cultures of

11
enteric bacteria were injected either in a cell-attached state or with
Freund's adjuvant (Gorzynski et al. , 1963; Neter et al • / 1964; Whang,
Cohen, and Neter, 1965). Additional investigations revealed that
separation of the CA from the O antigen made the CA antigen highly
immunogenic (Suzuki, Gorzynski, and Neter, 1964).

Conversely,

mixtures of the CA and O antigens failed to stimulate production of CA
antibody in high titers.
A protein-lipopolysaccharide complex has been equated with
the O antigen (Boivin, Mesrobeanu, and Mesrobeanu, 1933; Morgan and
Partridge, 1941).

The reactive sites of the O antigen of a particular

microorganism appear to be located in the lipopolysaccharide moiety.
Protein can be separated from the lipopolysaccharide by a phenol-water
extraction method (Westphal, Luderitz, and Bister, 1952).

Mild acid

hydrolysis separates the polysaccharide from the glucosamine-containing
lipid designated as lipoid A (Westphal and Luderitz,

1954).

Both

endotoxin and its lipoid A component were demonstrated to suppress
production of antibodies to CA when injected simultaneously with CA
(Suzuki et al. , 1964; Whang and Neter, 1967).

However, interference

with antibody production by lipopolysaccharide or lipoid A did not take
place when the inhibitors and the CA were injected separately.

Neither

inhibitor, moreover, prevented immunologic priming since animals
produced significant antibody titers when subsequent injections of the
antigens were administered (Neter et al. , 1966).

12
Several toxic effects have been associated with endotoxin
isolated from the CA of Enterobacteriaceae.

Fever, leukopenia, non

specific enhancement of resistance, shock, and internal hemorrhage
have been attributed to the lipopolysaccharide (Edwards and Ewing,
1972).

It is not surprising, therefore, that Whang and Neter (1967)

showed that both lipopolysaccharide and its lipoid A component
inhibited the production of humoral antibodies against a common Gram
positive antigen also.

The common Gram positive antigen first

described by Rantz, Randall, and Zuckerman (1956) is associated with
a number of Gram positive organisms including Staphylococcus aureus.
The effect of bacterial lipids on the antibody response has led
to investigation of animal lipids as possible immunosuppressive agents.
Whang and Neter (1968) demonstrated that cardiolipin injected together
with either the common bacterial antigens of Enterobacteriaceae or that
of Gram positive bacteria inhibited synthesis of humoral antibodies, but
did not interfere with priming.

Separate simultaneous injections of

cardiolipin and common antigens did not diminish antibody response.
The inhibitor did not affect the antigenic determinant since common
antigens alone or in the presence of cardiolipin attached similarly to
erythrocytes. The effects of the cardiolipin on the immune response
appeared similar, if not identical, to those produced by lipopolysaccha
ride and its lipoid A component.
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Various bacterial antigens readily form complexes with serum
proteins and other substances (Neter et al. , 1952, 1958a,b; Springer
and Horton, 1964).

Since bacterial antigens are frequently exposed in

vivo to serum or its components, it appeared likely that normal serum
could have an effect on their immunogenicity.

Using the common Gram

negative antigen (CA-) or the Gram positive antigen (CA+), Whang and
Neter (1969) showed that normal rabbit serum almost completely prevented
the antibody response to both antigens when the antigens were incubated
with serum prior to injection.

Inhibition of antibody response also

occurred with rabbit plasma and human, guinea pig, or calf serum.

That

antibodies were not responsible for the effect was suggested by the fact
that whole calf serum or its gamma globulin fraction inhibited antibody
response equally well.

Furthermore, removal of bacterial antibodies

from normal rabbit serum did not abolish the immunosuppressive effect.
Serum did not mask the antigenic determinants since the antigens
reacted equally well with specific antibodies both before and after
incubation with serum.

Whang and Neter postulated that the inhibitor

formed a complex with the antigen and that immunosuppression by
serum affected early stages of the immune response.
Thus, it would seem that immunosuppressive properties may not
be limited to specific lipid fractions, but that various constituents of
serum, including gamma globulin, may promote a similar type of
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interference. Although there is a paucity of reports on the protein
moiety of endotoxin, one study showed that biologic activities of
lipoid A, such as pyrogenicity and toxicity, increased when lipid was
combined with inert protein (Westphal and Luderit£, 1954).
The single membrane that covers mycoplasmal cells is a typical
lipoprotein "unit membrane. " Lipid, the major fraction of which is
phospholipid, constitutes approximately one-third the dry weight of
mycoplasmal membranes (Razin, Argaman, and Avigan, 1963; Tourtellotte
et al • / 1963).

Some mycoplasmal membranes also contain free and

esterified cholesterol (Rothblat and Smith, 1961; Argaman and Razin,
1965).

The cholesterol is presumed to stabilize the phospholipid layer

of biological membranes (Ponder, 1961; Willmer, 1961).

Protein

constitutes the major component of mycoplasmal membranes and averages
close to 5 0% of the dry weight (Razin, 1967).

Small amounts of carbo

hydrate, RNA, and DNA have also been reported to be present in
mycoplasmal membranes (Razin, 1967).
Since the composition of mycoplasmal membranes tends to
mimic that of the culture media, it seems plausible that mycoplasmas
could act as vehicles for immunosuppressive agents.

The first studies

which implicated M_. arthritidis with an immunosuppressive effect
employed in vitro systems.

Spitler, Cochrum, and Fudenberg (1968)

reported the in vitro inhibition of phytohemagglutinin (PHA)-stimulated
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lymphocytes both by heat-killed and by lysed M_. arthritidis cells.
Non-viable mycoplasmas inhibited both DNA and RNA synthesis by
PHA-stimulated cells. The inhibition could be reversed by removing
mycoplasmal components with thorough washing.

Killed M_. arthritidis

cells did not destroy lymphocytes, form a complex with PEA, or compete
for binding sites on cell surfaces. Those investigators suggested that
membrane-associated materials of this organism may be responsible for
the immunosuppressive effect.
Using extracts from 10 Mycoplasma species, Simberkoff,
Thorbecke, and Thomas (1969) showed inhibition of lymphocyte mitosis
in vitro, but no depression of the hemagglutinin response to sheep red
blood cells in vivo in rats or mice.

The capacity to inhibit mitosis and

transformation was correlated with the requirement for arginine by
Mycoplasma species.

The authors postulated that the arginine

dihydrolase enzyme system of mycoplasmas was responsible for the
inhibition of lymphocyte mitosis.

The lack of demonstrable interference

in antibody formation in vivo was explained as failure to bring about
complete arginine depletion.
Of particular interest is a recent report by Kaklamanis and
Pavlatos (1972) on the immunosuppressive effect of M_. arthritidis (PN)
on humoral as well as cellular responses of rats to the Pseudomonas
phage 0 5.

Simultaneous injection of rats with mycoplasmal cells and
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phage produced partial or complete suppression of phage-neutralizing
antibody. Administration of M,. arthritidis after the primary injection of
a two-inocula phage immunization schedule had a similar effect.
Moreover, lymphocytes isolated from infected animals demonstrated
diminished response to PHA.

STATEMENT OF THE PROBLEM

The passive uptake of growth media components by mycoplasmal
membranes suggested that alterations in growth medium may influence
antigenic or arthritogenic properties of M_. arthritidis in a rodent host.
The greater osmotic stability contributed by oleic acid to the
saprophyte, MR laidlawii, led to speculation that increased osmotic
resistance might be achieved by addition of oleic acid to culture media
of M_. arthritidis.

It appeared likely that osmotic stability could affect

virulence of the organism by prolonging the survival time in the host.
Furthermore, immunosuppression by lipids associated with
Enterobacteriaceae and by a number of animal sera against CA(-) or
CA(+) suggested that lipid-rich membranes of M_. arthritidis may affect
immune responses to these antigens in a similar manner.

The propensity

of those organisms to become associated with immunoglobulin components
of culture media could also influence immune responses to specific
antigens.

The ubiquitous nature of mycoplasmas and the demonstrated

interference with humoral responses in rodents by M_. arthritidis
suggested that membrane components could affect antibody production
in a non-rodent host.
It was the purpose of this study 1) to determine the effect of an
oleic acid-enriched growth medium on arthritogenic properties of an
17

18
animal-passaged and a laboratory-maintained strain of M. arthritidis
in rats, 2) to study the effect of oleic acid enrichment on the CF and on
the MI immune responses of rats to a passaged strain of M_. arthritidis,
3) to observe any influence of an oleic acid-supplemented medium on
the survival time of M_. arthritidis in vitro, 4) to demonstrate the effect
of the administration of pre-incubated mixtures of M. arthritidis
membranes and CA(-) or CA(+) on the HA response of the rabbit to CA(-)
or CA(+), and 5) to demonstrate the effect of the administration of
pre-incubated mixtures of M_. arthritidis membranes and CA (-) or CA(+)
on the MI antibody response of the rabbit to M. arthritidis.

MATERIALS AND METHODS

Organisms.

M. arthritidis (158P10) obtained from B. C. Cole,

University of Utah College of Medicine, Salt Lake City, Utah, was
used throughout the study.

E. coli (014) obtained from the American

Type Culture Collection of Bethesda, Md., and a strain of
coagulase-positive S^. aureus isolated from a clinical specimen at
Loma Linda University Hospital, Loma Linda, Ca., respectively, were
employed for preparation of CA(-) and CA(+).
Culture techniques.

M. arthritidis was grown on mycoplasmal

agar or in broth (BBL) supplemented with 20?4 sterile horse serum (v/v).
10% fresh yeast extract (v/v), and 1000 units/ml of penicillin for 48 to
72 hr at 37 C.

Oleic acid (Calbiochem. , San Diego, Ca.) in quantities

of 50 to 200 pg/ml was added to selected broth cultures.

E_. coli (014)

and j3. aureus were individually grown on brain veal agar (Difco) in
Kolle flasks for 18 hr at 37 C.
Estimation of colony-forming units (CPU) of M. arthritidis.
CPU of _M. arthritidis were estimated by a modification of the technique
of Miles and Misra (1938).

Ten-fold dilutions of broth cultures were

made in mycoplasmal broth and streaked in 0.01 ml amounts by means
of a calibrated loop on mycoplasmal agar plates measuring 50 mm in
diameter. After incubation at 37 C for 48 hr, duplicate plates containing
19
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CFU between 20 and 200 were counted.

CFU per ml were calculated by

averaging CFU and multiplying by the dilution factor.
Preparation of M. arthritidis membranes.

M. arthritidis (158P10)

was cultured three successive times in rabbit-infusion broth enriched
with rabbit serum and arginine hydrochloride (Taylor-Robinson et al. ,
1963; Cole et al. , 1967).

The rabbit-infusion broth was prepared by

grinding 10 g of rabbit meat in a Waring blender in 80 ml of distilled
water and heating to boiling. After standing for 1 hr, the mixture was
filtered through gauze and Whatman#! filter paper.

Peptone (0.8 g),

sodium chloride (0.4 g), and arginine hydrochloride (0.45 g) were added.
and the mixture was heated to dissolve the ingredients.

The broth was

adjusted to a pH of 7.8 and autoclaved.
Immediately before use, 5% rabbit serum (v/v) and 5% fresh
yeast extract (v/v) were added. Ten ml aliquots of enriched rabbitinfusion broth were inoculated with 1.0 ml aliquots of enriched myco
plasmal broth containing 1 X 10^ M_. arthritidis (158P10) and incubated
at 37 C for 48 hr.

The 10 ml broth cultures were transferred aseptically

to 90 ml aliquots of enriched rabbit-infusion broth. After incubation at
37 C for another 48 hr, the CFU were estimated as previously described.
Cells were harvested by centrifugation at 10,000 X g for 30 min in a
model RC-2 refrigerated centrifuge (Ivan Sorvall Inc., Norwalk, Conn.).
Each pellet was washed in 3 0 ml of phosphate hemagglutination buffer
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(pH 7.3; BBL) and re-centrifuged at the same speed for 30 min.

The

cells were ruptured by osmotic shock in 4.0 ml of sterile distilled
water. After 30 min of incubation at 37 C, the mixtures were centrifuged
at 10,000 X g for 30 min, washed with another 4.0 ml of sterile distilled
water, sedimented again by centrifugation, and stored at -65 C.

The

membranes were thawed and diluted 1:10 in phosphate buffer immediately
prior to mixing with CA(-) or CA(+).
Preparation of Gram negative common antigen (CA-) and Gram
positive common antigen (CA+). E_. coli (014) or IS. aureus cells grown
in Kolle flasks for 18 hr were suspended in 25 ml of phosphate hemag
glutination buffer (pH 7.3; BBL) per Kolle flask (Suzuki et al. , 1964).
Suspensions of Gram negative organisms were transferred to sterile
centrifuge tubes, heated in boiling water for 1 hr, and centrifuged at
10,000 X g for 20 min in a refrigerated centrifuge model RC-2 (Ivan
Sorvall Inc • / Norwalk, Conn.).

The supernates were mixed with

ethanol to a final ethanol concentration of 85% and allowed to stand at
room temperature for 18 hr. After centrifugation at the same speed for
another 2 0 min, the supernates were allowed to evaporate to dryness at
37 C and the residue was re-dissolved in phosphate buffer to the
original volume of 25 ml.
Suspensions of Gram positive organisms were treated similarly
except that, since the CA(+) is ethanol insoluble, the sediment obtained
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after ethanol treatment and centrifugation at 10,000 X g for 20 min was
re-dissolved in phosphate buffer to the original volume of 25 ml.

Both

antigens were stored at 5 C and diluted 1:10 in phosphate buffer prior
to use.
Production and scoring of arthritis.

Male albino rats (Sprague-

Dawley, Gilmore, Ca.) 6 to 8 weeks of age and weighing between 200
and 300 g were injected iv in groups of ten with mycoplasmal suspensions.
The numbers of viable mycoplasmas injected ranged from 1.0 to 1.8 X
10

g

and were contained in 1.0 ml volumes. All animals were examined

and scored for arthritis and paralysis at 2, 4, 6, 8, 10, 14, and 21 days
after injection.
to 105 days.

Selected animals were scored at additional intervals up

The severity of arthritis in each limb joint was rated on a

scale of 0 to 4.

Joints were scored as +1 if only a minimum amount of

edema with no redness was detected.

Mild edema with redness was

scored as +2. A score of +3 was assigned to joints showing moderate
edema with both redness and tenderness.

Joints showing marked edema.

redness, and tenderness were scored as +4.

Paralysis was scored as

0.5 or 1 for each limb involved according to the method of Cole et al.
(1969).

Total scores for limb joints and paralysis of limbs were

recorded and used as a measure of the severity of disease.
arthritis scores were calculated for each time period.

Mean

Variance between

arthritis scores for animals inoculated with organisms grown with and
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without enrichment of oleic acid was determined for days 4, 6, 8, 10,
14, and 21. All animals were weighed at weekly intervals through the
third week.
Immunization of rabbits.

Male New Zealand rabbits weighing

between 2 and 3 kg were given three 1.0 ml iv injections of mixtures of
the CA(-) or the CA(+) and membranes at seven-day intervals.

Mixtures

consisted either of 0. 1 ml of the CA(-) or the CA(+) and 0.9 ml of
membranes (1:10) or 0.5 ml of the CA(-) or the CA(+) and 0.5 ml of
membranes (1:1). All mixtures were incubated in a water bath at 37 C
for 30 min prior to injection into the marginal ear vein.

Rabbits of

similar weight were immunized in an identical manner with the CA(-) or
the CA(+)-phosphate buffer mixtures (1:10 or 1:1).

Single booster

injections of the same materials were given to selected animals after
an appropriate rest period during which their antibody titers fell to the
pre-immunization levels.
Complement-fixation (CF) test.

CF antibody titers were

demonstrated by the one-fifth quantitative test of Kolmer and Boerner
(1945) on rat sera obtained prior to inoculation and at 4, 7, 14, 21, and
105 days after injection of mycoplasmas.

Serum specimens were

inactivated at 56 C for 30 min and diluted 1:5 with 0.85% saline
containing 0.01% magnesium sulfate.

Two-fold dilutions of serum

samples (0.2 ml) were made in the salt solution.

M. arthritidis CF
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antigen (Microbiological Associates Inc., Bethesda, Md.) was diluted
1:8 and added in 1.0 ml amounts.

The complement (Hyland Laboratories,

Costa Mesa, Ca.) was titrated and diluted so that exactly two units
were contained in 0.2 ml quantities.

The 0.2 ml aliquots of diluted

complement were added to all tubes and the racks of tubes were shaken
to mix the contents. After 15 to 18 hr in a refrigerator at 6 to 10 C, the
tubes were incubated in a water bath at 37 C for 10 min.

The titrated

hemolysin was diluted so that 0.1 ml contained 2 units of hemolysin.
Diluted hemolysin in 0.1 ml amounts was added to all tubes.

Finally,

a 1.0 ml aliquot of a washed 2% sheep erythrocyte suspension was
added to each tube.

The mixtures were shaken and then incubated in a

water bath at 37 C for 1 hr.

The highest dilution of serum producing a

3+ or 4+ reaction was considered the end-point titer.
Passive hemagglutination (HA) test.

Titers of HA antibodies

against CA(-) or CA(+) were determined on the rabbit sera obtained prior
to immunization and at 3, 7, 14, and 21 days after the initial immuniza
tion and, again, at 7 and 14 days after the booster injections according
to the technique of Whang and Neter (1967).

Rabbit erythrocytes (2.5%)

were washed three times in phosphate hemagglutination buffer (pH 7.3;
BBL).

The CA(-) or CA(+) diluted 1:10 in buffer was added to packed

erythrocytes to restore original volumes.

Mixtures were incubated at

37 C for 3 0 min and washed three times in buffer to remove unattached
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antigen.

Serum samples were inactivated at 56 C for 30 min and serial

two-fold dilutions (0.2 ml) were mixed with equal volumes of antigencoated or unaltered erythrocytes (2.5%).
in a water bath at 37 C for 3 0 min.

The mixtures were incubated

HA titers were determined after

centrifugation for 20 min at 1,300 X g by the pattern method using a
concave mirror.

Sera of known titer for CA(-) or CA(+) for control

purposes were graciously supplied by E. Neter (Children's Hospital,
Buffalo, N.Y.).
Metabolism-inhibition (MI) test.

Titers of MI antibody were

determined by a modification of the technique of Purcell et al. (1966)
described by Cole et al. (1969); arginine hydrochloride (1% w/v) was
added to mycoplasmal broth containing 20% sterile horse serum (v/v),
10% fresh yeast extract (v/v) and 1000 units/ml of penicillin.

Phenol

red (0. 0002% w/v) was employed as the indicator for detection of pH
changes resulting from ammonia production.

The phenol red-arginine

broth was adjusted to a pH of 7.2. Rat or rabbit sera collected prior to
injection and at 3 or 4, 7, 14, and 21 days subsequently were
inactivated at 56 C for 30 min and diluted 1:10 with phosphate buffer.
Two-fold dilutions of serum samples (0.25 ml) were made in the phenol
red-arginine medium.

M. arthritidis cells in 1.0 ml aliquots of standard

mycoplasmal broth containing 1000 CPU were added to all tubes except
those in the control series.

Guinea pig complement (Hyland Laboratories,
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Costa Mesa, Ca.) was diluted 1:10 in sterile saline and added in 0. 1
ml amounts to all tubes.
red-arginine broth.

Volumes were brought to 0.9 ml with phenol

The tubes were incubated at 37 C until the phenol

red in the control tubes containing organisms but no antisera had changed
from orange to red.

The highest serum dilution without color change was

considered the end point.

Sera containing high titers of MI antibodies

(Microbiological Associates, Inc., Bethesda, Md.) were used as
controls.
Histopathological procedures.

Several rats from the groups

receiving M_. arthritidis, grown with or without the oleic acid enrichment.
were sacrificed and selected joints were fixed in buffered 10% formalin.
Joints were decalcified in 5% nitric acid for 24 hr.
stained with hematoxylin and eosin.

Sections were

RESULTS

Development and course of arthritis in rats receiving passaged
M. arthritidis grown with (158P10-QL) and without (158P10) oleic acid
enrichment.
Groups of ten male albino rats were injected via the caudal
vein with either 1.6 X 10^ CFU of M_. arthritidis (158P10) grown in
mycoplasmal broth supplemented with horse serum, yeast extract, and
penicillin or 1.8 X 10^ CFU of M_. arthritidis (158P10-OL) grown in an
identical medium containing 200 pg of oleic acid per ml of broth.
Although the incidence of arthritis produced by culture 158P10-OL
surpassed the incidence of the disease produced by culture 158P10 by
only two, the mean arthritis scores of animals receiving the organisms
grown in oleic acid-enriched broth were higher on all scoring days
(Table 1).

The highest mean score for animals injected with culture

158P10-OL occurred on day eight and was nearly quadruple the mean
maximum score of animals inoculated with culture 158P10.

In both

groups, however, the mean arthritis scores on day 21 were equal to or
slightly lower than scores on day four.

When variance was calculated,

variations in mean arthritis scores had p-values of <0.01 on days 6, 8,
and 10 (Table 2).
Mean scores for arthritic rats were demonstrably higher for
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Table 1. Arthritic Response Induced by iv Injection of Rats with Passaged M_. arthritidis Grown with
(158P10-OL) and without (158P10) Oleic Acid Enrichment (200 |jg/ml)

Organism

158P10
158P10-OL

Mean Scores on Day
8
14
10

Inoculum

Incidence

4

6

1.6 X 109

7/10

5.0

8.9

8.8

7.2

8.4

4.8

1.8 X 109

9/10

12.4

32.4

34.9

29.5

24.7

12.4

21

CO
00

29

Table 2. Variance of Mean Scores for Animals Receiving |4. arthritidis
(158P10) and (158P10-OL)

Day

t Score

p-Value

4

- 2.1279

< 0.05

6

- 3.4820

< 0.01

8

- 3.4966

< 0.01

10

- 3.9558

< 0.01

14

- 3.1035

< 0.02

21

- 1.7578

< 0. 10
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animals receiving culture 158P10-OL for the first 50 days after inoculation
(Figure 1).

Only after 78 days did mean scores of the two groups

decline to similar values of approximately five.

The largest difference

in mean scores of arthritic animals amounting to 24.1 occurred eight
days subsequent to injection of mycoplasmas.

The highest individual

score for animals receiving the 158P10-OL culture was 61 on day eight,
whereas the highest individual score for animals inoculated with the
158P10 culture was 42 on the same day.

One animal receiving the

158P10 culture expired prior to the 21st day.
Joint involvement.

The total number of joints involved in

arthritic animals receiving the 158P10-OL culture exceeded the number
of joints in arthritic animals injected with organisms grown in the
absence of oleic acid by 93 (Tables 3 and 4).

In both groups, hind

limbs were more commonly affected. Ankle and metatarsal joints of
hind limbs and wrist and metacarpal joints of forelimbs were most
frequently involved.

It, therefore, appeared that mean differences in

arthritis scores could not only be explained by severity of particular
joint lesions, but also by differences in numbers of joints affected.
Typical ankle and hind limb digital involvement may be
observed in Figures 2 and 3.

Macroscopic lesions were associated

with edema, redness, and tenderness, and also frequently with marked
disfigurement which tended to remain after the swelling had disappeared.

Figure 1.
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Table 3. A Comparison of the Numbers of Forelimb Joints Affected in Animals Receiving
M. arthritidis (158P10) and (158P10-OL)

Joint

Organism
158P10

Elbow
Wrist
Metacarpal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal

1
1
1
2
2
2
3
3
3
4
4
4
Total

158P10-OL

0
3

0
7

4
1
1
1

15
1
1
1

2
2
2

6
6
6

1
1
1
1
1

4
4
4

2

2
2
2

23

61

GJ
CO

Table 4. A Comparison of the Numbers of Hind Limb Joints Affected in Animals Receiving
M. arthritidis (158P10) and (158P10-OL)

Joint

Organism
158P10

Ankle
Metatarsal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Distal Phalangeal

8
7

1
1
1

1
1
1
1
1
1
1

2
2
2
3
3
3

2
2

4
4
4

1
1
2
2

5
5

Total

158P10-OL

7

16
3
3
3
3
3
3
5
7
7
3
6
6

9

4

7

36

91
u>

Figure 2.

Macroscopic Appearance of the Hind Limb Joints of a Rat 7
Days after Injection of M_. arthritidis (158P10-OL) Showing
Edema and Redness of the Ankle and Digital Joints

Figure 3.

Macroscopic Appearance of the Hind Limb Joints of a Rat 14
Days after Injection of M_. arthritidis (158P10) Showing
Edema and Disfigurement of the Ankle and a Phalangeal
Abscess
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Although markedly edematous lesions were less frequent on the forelimbs,
such lesions did occur more often in animals receiving culture
158P10-OL (Figure 4). Occasionally, abscesses occurred on the digits
or the metacarpal joints (Figure 5).

No recurrence of arthritis was

noted from macroscopic examination of joints.
Weights of animals.

Weight losses of animals receiving

culture 158P10-OL reflected the severity of the arthritis (Table 5).
Rats injected with F4. arthritidis grown under the usual laboratory
conditions began to gain slightly by the end of the second week.

The

weight gains over initial weights were similar three weeks after
inoculation.

The observed weight gains seemed to accompany the

decline of joint involvement after 21 days.
Histopathological characteristics.

Selected animals receiving

both cultures of M_. arthritidis were sacrificed at 4, 7, 14, and 25 days.
Histological examination of the affected joints from both groups revealed
acute exudation of the joint spaces with marked destruction of the
articular cartilage within four days after injection of mycoplasmas
when compared with a histological section of an uninvolved joint
(Figures 6, 7, and 8).

By day seven, representative joints from animals

of both groups demonstrated extension of exudates into muscle tissue
with resultant acute myositis (Figures 9 and 10). At the end of 14 days.
there was marked exudation of joint spaces with focal disruption of

Figure 4.

Macroscopic Appearance of the Forelimb Joints of a Rat 7
Days after Injection of M. arthritidis (158P10-OL) Showing
Marked Edema of Both Forepaws

Figure 5.

Macroscopic Appearance of the Right Forelimb Joints of a Rat
7 Days after Injection of M_. arthritidis (158P10-OL) Showing
a Metacarpal Abscess
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Table 5.

Per Cent Loss or Gain in Weight by Week of Rats Injected with
Passaged M. arthritidis Grown with (158P10-OL) and without
(158P10) Oleic Acid Enrichment

Organism
1

Week
2

3

158P10

-4.9

+1.0

+11.0

158P10-OL

-8.1

-7.1

+ 9.2

Figure 6.

Microscopic Appearance of an Uninvolved Right Hind Limb
Joint of a Rat. Hematoxylin and Eosin: X 28
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Figure 7.

Microscopic Appearance of a Left Hind Limb Joint of a Rat
4 Days after Receiving M_. arthritidis (158P10) Showing
Acute Exudation of Joint Space and Involvement of the
Ligament. Hematoxylin and Eosin: X 28
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Figure 8.

Microscopic Appearance of a Right Hind Limb Joint of a Rat
4 Days after Receiving M. arthritidis (158P10-OL) Showing
Acute Exudation of the Joint Space and Marked Destruction
of the Articular Cartilage. Hematoxylin and Eosin: X 66
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Figure 9.

Microscopic Appearance of a Left Forelimb Joint of a Rat 7
Days after Receiving M_. arthritidis (158P10) Showing
Severe Acute Myositis. Hematoxylin and Eosin: X 28
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Figure 10.

Microscopic Appearance of a Hind Limb Joint of a Rat 7 Days
after Receiving Ivl. arthritidis (158P10-OL) Showing Exudate
from the Joint Extending into the Muscle and Acute Myositis.
Hematoxylin and Eosin: X 66
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articular cartilage and osteitis (Figures 11 and 12).

A representative

hindpaw joint of an animal receiving culture 158P10 showed a similar
histological picture on day 25 (Figure 13).

A section of a metatarsal

joint of an animal injected with culture 158P10 revealed organization
of the exudate with marked fibrosis of the joint space and apparent
regeneration of the articular cartilage on day 25 (Figure 14).

Thus,

repair appeared to be evident as early as 25 days after inoculation with
mycoplasmas.
Serological studies.

No MI antibody could be demonstrated in

a total of 120 specimens of rat sera taken from both groups of animals
prior to injection or at 4, 7, 14, 21, and 35 days after injection.

CF

antibody was evident, however, in the same animals as soon as four
days after the animals received the mycoplasmas.

Rats injected with

culture 158P10 with arthritis scores >20 had CF titers of 40 or less.
whereas those with scores <20 had CF titers of 40 to 2 98 (Table 6).

A

mean maximum CF titer of 2 98 was obtained for nine animals with
arthritis scores of <20 on day 14.

No individual titer exceeded 640.

At the end of 105 days, CF titers on the same nine animals averaged
^ 40.

Although higher CF titers did occur in animals with scores > 20,

the sampling of animals with scores > 20 is too small to make a valid
comparison.
Greater numbers of animals injected with culture 158P10-OL

Figure 11.

Microscopic Appearance of a Right Hind Limb Joint of Rat
14 Days after Receiving IVR arthritidis (158P10) Showing
Acute Exudation of the Joint Space, Focal Destruction of
the Articular Cartilage, and Osteitis. Hematoxylin and
Eosin: X 28
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Figure 12.

Microscopic Appearance of the Left Ankle Joint of a Rat 14
Days after Receiving M_. arthritidis (158P10-OL) Showing
Marked Exudation in the Joint Space and Focal Disruption
of the Articular Cartilage. Hematoxylin and Eosin: X 66
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Figure 13.

Microscopic Appearance of a Right Hind Limb Joint of a Rat
25 Days after Receiving M_. arthritidis (158P10) Showing
Marked Exudation in the Joint Space and Destruction of the
Articular Cartilage. The Fibrous Membrane Overlying Bone
is Suggestive of Abscess Formation in the Joint. Hematoxylin
and Eosin: X 28
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Figure 14.

Microscopic Appearance of a Right Metatarsal Joint of a Rat
25 Days after Receiving M_. Arthritidis (158P10-OL) Showing
Marked Organization of Exudate, Marked Fibrosis of Joint
Space, and Apparent Regeneration of Articular Cartilage.
Hematoxylin and Eosin: X 28
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Table 6.

Complement-Fixing (CF) Antibody Response in Rats Receiving Passaged M. arthritidis (158P10)

Day

No. of animals with
mean score <20

Mean CF
titer

4

9

86

1

10

7

9

126

1

20

14

9

298

1

40

21

9

'v 145

0

105

9

^ 40

0

No. of animals with
mean score >20

Mean CF
titer

cr>

o

61
had scores <20 (Table 7).

The mean maximum titer of 278 was obtained

for eight animals with arthritis scores >20 on day seven.
titer exceeded 640.

No individual

The average maximum titer of animals with scores

< 20 was ^217 on day 14. At the end of 105 days, CF titers on eight
animals with scores <20 declined to 40.

Thus, the CF titers of animals

injected with culture 158P10-OL did not show significant variation in
animals with arthritis scores above or below 20.

Declines in CF titers

with time appeared similar.

Development and course of arthritis in rats receiving laboratorymaintained M. arthritidis grown with (158L5-OL) and without oleic acid
(158L5) enrichment.
Since oleic acid in the growth medium increased the virulence
of the passaged M_. arthritidis (158P10), a similar experiment was set
up using a laboratory-maintained culture of the same strain.

Groups of

ten rats were injected via the caudal vein with either 1.0 X 10

Q

CFU of

laboratory-maintained JVL arthritidis (158L5) grown in mycoplasma broth
supplemented with horse serum, yeast extract, and penicillin or
1. 1 X 10^ CFU of the same culture of M. arthritidis (158L5-OL) grown
in an identical medium to which 200 pg of oleic acid per ml of broth
had been added.
Eight of 10 animals in each group exhibited macroscopic

Table 7.

Day

Complement-Fixing (CF) Antibody Response in Rats Receiving Passaged M_. arthritidis
(158P10-OL)

No. of animals with
mean score <20

Mean CF
titer

No. of animals with
mean score >20

4

8

v 21

2

7

2

100

8

278

14

4

^217

5

100

21

4

165

3

87

105

8

40

0

Mean CF
titer
%

15

<T>
CO

63

arthritic lesions.

Mean maximum arthritis scores of the two groups did

not differ significantly from each other or from the mean maximum score
of animals injected with the passaged culture grown without oleic acid.
Mean scores of animals receiving the laboratory-maintained cultures
reflected the delay in production of disease of maximum severity (Table
8).

Maximum scores of 8.1 and 9.7 for cultures 158L5 and 158L5-OL,

respectively, were obtained on day 10.
Joint involvement. Arthritic lesions were almost equally
distributed in the hind limb and the forelimb joints (Tables 9 and 10).
A total of 16 hind limb joints and 22 forelimb joints were affected in
animals receiving culture 158L5. Animals inoculated with the laboratorymaintained culture grown in the oleic acid-supplemented broth developed
macroscopic lesions in two hind limb joints and six forelimb joints only.
Wrist, metacarpal, and ankle joints were most commonly involved.

The

highest individual score of 37 was obtained for an animal injected with
the mycoplasmas grown in the presence of the oleic acid enrichment.
That animal and one other with a maximum arthritis score of 10 expired
after the second week.

No attempt was made to score joints beyond 21

days.
Weights of animals.

Weights of animals receiving laboratory-

maintained cultures of M_. arthritidis (158L5) or (158L5-OL) reflected
disease of lesser severity than animals inoculated with passaged

Table 8. Arthritic Response Induced by iv Injection of Rats with Laboratory-Maintained M_. arthritidis
Grown with (I58L5-OL) and without (158L5) Oleic Acid Enrichment (200 jig/ml)

Organism

Inoculum

Incidence
4

6

Mean Scores on Day
14
8
10

21

158L5

1.0 X 109

8/10

1.3

3.7

7.6

8. 1

6. 9

4.7

158L5-OL

1. 1 X 109

8/10

1.8

5.9

7.7

9. 7

9.0

5.7

Table 9. A Comparison of the Numbers of Forelimb Joints Affected in Animals Receiving M. arthritidis
(158L5) and (158L5-OL)

Joint

Elbow
Wrist
Metacarpal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal

Organism

1
1
1
2
2
2
3
3
3

158L5

158L5-OL

0
5
6
0
0
0
0

0
2
2
0
0
0
0
0
0

1
0
0
2
2
0
0
0

4
4
4
Total

16

1
1
1
0
0
0
6

cr>

Cn

Table 10. A Comparison of the Numbers of Hind Limb Joints Affected in Animals Receiving M_. arthritidis
(158L5) and (158L5-OL)

Joint

Ankle
Metatarsal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Middle Phalangeal
Distal Phalangeal
Proximal Phalangeal
Distal Phalangeal

Organism

1
1
1
2
2
2
3
3
3

158L5

158L5-OL

5
2
2
2
2
0

1
1

0
0
0
0
0

0
0
0
0
0
0
0
0
0
0
0
0
0
0

22

2

1
1
2

4
1

4
4
4
5
5

Total

CD
CD
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organisms (Table 11). All animals exhibited substantial weight gains.
Rats receiving culture 158L5 averaged a 10.2% gain, whereas a 14.3%
average gain was observed in rats in which culture 158L5-OL was
introduced.

By the second week, animals injected with laboratory-

maintained organisms grown without oleic acid enrichment had gained
almost twice as much as those animals injected with the same organism
grown in the presence of oleic acid.

By the third week, weight gains

appeared more consistent between the two groups.
Cell yield.

Since osmotic stability of M_. arthritidis membranes

could contribute to in vivo as well as in vitro viability, an experiment
was set up to determine cell yields of culture 15 8L5 grown with and
without oleic acid enrichment (50 pg/ml) during a 96 hr period.

CPU

were determined at 24, 48, 72, and 96 hr by the surface inoculation
technique previously described from triplicate cultures.

Not only were

CPU higher for organisms grown in medium containing oleic acid, but
mycoplasmas remained viable for a longer period of time (Figure 15).
At 48 hr, mean CPU for both sets of cultures approximated 10^, but
viable organisms started to decline at 72 hr in the broths containing no
oleic acid.

Conversely, the numbers of organisms increased in the

oleic acid-supplemented broths. After 72 hr, a sharp decline in CPU
occurred in the absence of oleic acid, whereas only minimum losses in
CPU obtained in oleic acid-enriched broths.

68

Table 11.

Per Cent Loss or Gain in Weight by Week of Rats Injected
with Laboratory-Maintained M_. arthritidis Grown with
(158L5-OL) and without (158L5) Oleic Acid Enrichment

Organism

Week

1

2

3

158L5

+10.2

+33.0

+52.3

158L5-OL

+14.3

+19.7

+45.6

Figure 15.

Cell Yields of Laboratory-Maintained M.arthritidis Grown with (A
( # — — © ) Oleic Acid Enrichment

A) and without

NUMBER OF CFU OF M.arthritidis
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Immune responses of rabbits receiving simultaneous injections of CA(-)or CA(+)~ membrane mixtures.
Male New Zealand rabbits were selected as non-rodent hosts
to receive simultaneous injections of CA(-)- or (CA+)-M_. arthritidis
membrane mixtures. All animals received the primary immunizing
injections, but only selected animals received the booster injections.
Primary and secondary responses to CA(-) or CA(+) were assessed by
measurement of HA antibody titers against the common antigens.
Primary and secondary responses to 1VL arthritidis membranes were
determined by measurement of the MI antibody titers.
Primary HA response to CA(-).

Five male New Zealand rabbits

were inoculated iv three times with 1.0 ml pre-incubated mixtures of
CA(-)-M. arthritidis membranes (1:10) at seven-day intervals. Another
group of five male New Zealand rabbits received injections of preincubated CA(-)-buffer mixtures (1:10) at the same time intervals.
Serum samples were taken prior to immunization and on 3, 7, 14, and
21 days after the final injections.

The antibody response to CA(-) was

measured by means of the passive hemagglutination of rabbit cells
coated with CA(-) from E_. coli (014) as the indicator antigen.

One

animal was eliminated from the control group because it failed to produce
measurable titers. On all sampling days, the mean HA titers were lower
for animals receiving CA(-)-membrane mixtures (Table 12). A mean HA

Table 12.

Effect of M_. arthritidis Membranes (1:10) on Primary Hemagglutinin Responses of Rabbits
to CA(-)

Immunizing Materials

Animal No.
0

CA(-)+ buffer (1:10

CA(-)+M_. arthritidis
membranes (1:10)

Hemagglutinin Titer on Day
3
7
14

21

1

<10

10

80

40

10

2

<10

40

80

80

80

3

<10

80

80

160

160

4

<10

320

160

320

160

Mean

<10

113

125

150

103

6

<10

20

20

20

<10

7

<10

20

40

40

10

8

<10

40

80

40

20

9

<10

40

160

80

80

10

<10

160

160

160

80

Mean

<10

56

92

68

M0

CO
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titer of 68 occurred on day 14, whereas the mean titer of the control
group was 150.

Three animals in the test group yielded titers of 20 or

less on day 21, but three animals of the control group had titers of 80
or more on the same day.
control group was 320.

The single highest titer for an animal in the

Conversely, a maximum titer of 160 obtained

for two animals receiving mycoplasmal membranes.
In order to extend the sampling of animals and to determine the
possible effect of M_. arthritidis membranes in another dilution on rabbit
response to CA(-), 10 additional animals of similar weights were
immunized in an identical manner with pre-incubated mixtures of CA(-)buffer (1:10 or 1:1) or pre-incubated mixtures of CA(-)- M. arthritidis
membranes (1:10 or 1:1).

Serum samples were taken prior to immuniza

tion and at 3, 7, 14, and 21 days after the final injections.

HA

antibody to the CA(-) was determined as previously described. All
mixtures of the CA(-) and M_. arthritidis membranes inhibited antibody
response to the CA(-) when the titers of animals receiving the mixtures
were compared with the titers of animals receiving the CA(-) and buffer
(Table 13). Although the CA(-)-buffer mixtures (1:10) produced a mean
maximum HA titer of 3 60 by day seven, the mean maximum HA titer was
^35 in animals receiving CA(-)-membrane mixtures in the same propor/

tion.

Two animals of the test group had titers of <10 for the entire test

period.

When a five-fold increase of antigen was injected with an

Table 13.

Comparison of the Effect of M_. arthritidis Membranes (1:10) and (1:1) on Primary
Hemagglutinin Responses of Rabbits to CA(-)

Immunizing Materials

Animal No.
0

CA(-)+ buffer (1:10)

CA(-)+M_. arthritidis
membranes (1:10)

CA(-)+ buffer (1:1)

CA(-)+M_. arthritidis
membranes (1:1)

Hemagglutinin Titer on Day
14
7
3

21

11
12
Mean

<10
<10
<10

< 10
640
^325

80
640
360

80
320
200

80
320
200

13
14
15
16
Mean

<10
<10
<10
<10
<10

<10
<10
40
160
^55

<10
<10
40
80
^35

<10
< 10
40
80
^35

<10
<10
40
40
^ 25

17
18

<10
<10

<10
20

40
320

40
640

320
640

Mean

<10

^15

180

340

480

19
20
21
22

<10
<10
<10
<10

<10
<10
10
20

20
80
80
80

20
20
40
160

10
10
10
40

Mean

<10

M3

65

60

18

75

equal quantity of buffer, titers appeared to rise more slowly, but reached
a mean maximum of 480 on day 21.

Conversely, injection of the five

fold increase of the antigen with membranes (1:1) resulted in a mean HA
titer of only 18 on day 21 with a mean maximum titer of only 65 on day
7.

Three of the rabbits on day 21 had titers of only 10.
The magnitude of depressions of the immune response which

occurred with both dilutions of antigen and membranes may be seen in
Figures 16 and 17.

It is of some interest that a five-fold increase in

the amount of CA(-) produced a nearly triple mean maximum titer. Titers
did not differ substantially in animals receiving both dilutions of
CA(-)-membrane mixtures.

However, the mean values of control titers

suggested a far greater immunosuppressive effect using the CA(-) and
membranes in a 1:1 ratio.
Secondary HA response to CA(-).

Two control animals and two

test animals from each group receiving the CA (-)-membrane mixtures
(1:10) or (1:1) were each given a single booster injection of the same
material used for the primary immunization after a rest period of two
months during which the titers had returned to pre-immunization levels.
Serum samples were obtained prior to administration of booster doses
and 7 and 14 days later. All HA titers measured <10 prior to adminis
tration of booster injections.

The CA(-)-membrane mixtures of both

dilutions produced a diminution of antibody response to CA(-) when the

Figure 16.

Primary CA(-) Hemagglutinin Response in Rabbits Receiving CA(-)-M. arthritidis
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Figure 17.

Primary CA(-) Hemagglutinin Response in Rabbits Receiving CA(-)-M. arthritidis
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HA titers of animals receiving mycoplasmal membranes were compared
with those of animals receiving CA(-) in buffer (Table 14). The mean
maximum titer of the animals receiving the antigen-buffer mixtures
(1:10) peaked at 400 on day 14. Animals receiving the CA(-) plus
membranes (1:10) attained a mean maximum HA titer of ^25 on day 7
and demonstrated a mean titer of <10 on day 14.

When the CA(-)-buffer

mixtures (1:1) were administered, a mean maximum titer of 180 obtained
on day 14, whereas animals receiving the CA(-)-membrane mixtures
(1:1) had a mean maximum titer of only 80 which fell to 60 on day 14.
Primary MI antibody response to M. arthritidis membranes.

In

order to determine the effect of simultaneous injection of CA(-) and
M. arthritidis membrane antigens on the antibody response to
M. arthritidis, the MI titers of sera from four animals of each test
group and two animals of each control group were measured on serum
samples obtained prior to immunization and at 3, 7, 14, and 21 days
after the final immunizing injections. Ail animals receiving antigenmembrane mixtures produced measurable MI antibody titers (Table 15).
The mean titer for animals receiving the CA(-)-membrane mixtures
(1:10) peaked on day 14 at 960, whereas the mean maximum titer for
animals receiving the CA(-)-membrane mixtures (1:1) was 760 on day
14.

The highest individual titer of 1280 occurred in two animals of

each test group.

Sera obtained from animals receiving the CA(-) and

Table 14.

Comparison of the Effect of M_. arthritidis Membranes (1:10) and (1:1) on Secondary
Hemagglutinin Responses of Rabbits to CA(-)

Immunizing Materials

Hemagglutinin Titer on Day

Animal No.
0

CA(-)+ buffer (1:10)

CA(-)+M_. arthritidis
membranes (1:10)

CA (-)+ buffer (1:1)

CA(-)+M_. arthritidis
membranes (1:1)

7

14

11
12
Mean

< 10
< 10
< 10

320
320
320

160
640
400

13
14

< 10
< 10

<10
30

<10
<10

Mean

< 10

^25

<10

17
18
Mean

< 10
<_10
< 10

20
320
170

40
320
180

19
20

< 10
< 10

80
80

40
80

Mean

< 10

80

60

CO

Table 15.

Metabolism-Inhibiting Antibody Titers in Rabbits Following Primary Immunization with
CA (-)-M. arthritidis Membranes (1:10) and (1:1)

Immunizing Materials

CA (-) + buffer (1:10)

CA(-)+jM. arthritidis
membranes (1:10)

CA(-)+ buffer (1:1)

CA(-)+M_. arthritidis
membranes (1:1)

Metabolism-Inhibiting Antibody Titer on Day
21
7
14
0
3

Animal No.

11
12

< 10
< 10

< 10
< 10

<10
<10

< 10
< 10

<10
<10

Mean

< 10

< 10

<10

< 10

<10

13
14
15
16
Mean

<
<
<
<
<

<
<
<
<
<

10
10
10
10
10

<10
320
<10
<10
^88

1280
1280
640
640
960

1280
1280
640
640
960

17
18
Mean

< 10
< 10
< 10

< 10
< 10
< 10

<10
<10
<10

< 10
< 10
< 10

<10
<10
<10

<
<
<
<

10
10
10
10

40
40
< 10
< 10

360
1280
<10
<10

1280
1280
160
320

1280
1280
160
160

< 10

^25

'MIS

760

720

19
20
21
22
Mean

10
10
10
10
10

00
N3

83

buffer demonstrated no MI antibody activity.

In no instance did pre

immunization sera inhibit arginine utilization.
Secondary MI antibody response to M. arthritidis membranes.
Two animals of each test and each control group were selected for a study
of the secondary MI antibody response. After a two-month rest period
during which the MI antibody titers returned to <10, booster injections of
the same antigen-buffer or antigen-membrane mixtures were administered
iv.

Serum samples were obtained prior to administration of the booster

doses and after 7 and 14 days.

In all instances, titers were equal to

or greater than primary antibody responses (Table 16). Animals receiving
the CA(-)-membrane mixtures (1:10) produced a mean maximum titer of
1920 on day 14. A mean maximum titer of 1280 obtained on day 14 in
animals receiving the CA (-)-membrane mixtures (1:1).
Primary HA response to CA(+).

The immunosuppressive effect

of M_. arthritidis membranes on the primary and secondary responses of
rabbits to the CA(-) led to speculation that the effect might not be
limited to the CA(-).

In order to test membranes in another system,

M. arthritidis membranes prepared in an identical manner were mixed
with the CA(+) of S_. aureus.

Groups of four male New Zealand rabbits

were injected iv three times with 1.0 ml amounts of pre-incubated
CA(+)-membrane mixtures (1:10) or (1:1) at seven-day intervals. Groups
of two New Zealand rabbits were immunized in an identical manner with

Table 16.

Metabolism-Inhibiting Antibody Titers in Rabbits Following Secondary Immunization
with CA(-)-M. arthritidis Membranes (1:10) and (1:1)

Immunizing Materials

CA (-)+ buffer (1:10)

CA(-)+M_. arthritidis
membranes (1:10)

CA(-)+ buffer (1:1)

CA(-)+ M_. arthritidis
membranes (1:1)

Animal No.

Metabolism-Inhibiting Antibody Titer on Day
14
7
0

11
12

<10
<10

<10
<10

< 10
< 10

Mean

<10

<10

< 10

13
14

<10
<10

1280
1280

1280
2560

Mean

<10

1280

1920

17
18

<10
<10

<10
<10

<10
<10

Mean

<10

<10

<10

19

<10
<10
<10

1280
1280

1280
1280

1280

1280

20

Mean

00
4^

85

the CA(+)-buffer mixtures (1:10) or (1:1).

Serum samples were obtained

prior to immunization and at 3, 7, 14, and 21 days after final injections.
The antibody response to the CA(+) was measured by a passive hemag
glutination technique with rabbit cells coated with the CA(+) from
S_. aureus as the indicator antigen.
The substitution of mycoplasmal membranes for buffer in the
1:10 dilutions did not appear to substantially affect the titer or the time
of peaking (Table 17).

On day seven, the mean titer for control animals

was 80, whereas the mean titer for test animals was ^85.

On day 21,

titers averaged 50 for the control group and 45 for the test group. A
five-fold increase in antigen appeared to paralyze the immune response.
However, mixing the antigen with membranes in a 1:1 ratio seemed to
restore the ability of rabbits to respond to CA(+). An early mean anti
body titer of 28 0 was obtained for test animals as compared to M5 for
the control group.
Secondary HA response to CA(+). Two control and two test
animals from each group receiving CA (+)-membrane mixtures (1:10) or
(1:1) were given single booster injections of the same materials used
for primary immunization after a rest period of two months during which
titers returned to pre-immunization levels.

Serum samples were obtained

prior to administration of booster doses and 7 and 14 days later. All HA
titers measured <10 prior to administration of booster injections.

Table 17.

Comparison of the Effect of JVT* arthritidis Membranes (1:10) and (1:1) on Primary
Hemagglutinin Responses of Rabbit to CA(+)

Immunizing Materials

Animal No.
0

CA (+) + buffer (1:10)

CA(+)+Al. arthritidis
membranes (1:10)

CA(+)+ buffer (1:1)

CA(+)+ M. arthritidis
membranes (1: 1)

Hemagglutinin Titer on Day
14
7
3

21

23
24
Mean

< 10
< 10
< 10

160
160
160

80
80
80

40
80
60

20
80
50

25
26
27
28
Mean

<
<
<
<

10
10
10
10

320
80
10
10

< 10

105

160
160
<10
<10
%85

160
160
<10
<10
^85

80
80
<10
<10
M5

29
30
Mean

< 10
< 10
< 10

<10
20

<10
<10

<10
<10

^15

<10

<10

<10
<10
<10

160
640
160
160
280

160
160
160
160
160

80
80
80
80
80

20
80
40
80
80

31
32
33
34
Mean

<
<
<
<

10
10
10
10

< 10

00

oo
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Antigen-membrane mixtures (1:10) appeared to inhibit the secondaryresponse (Table 18).

Titers of <10 were obtained for animals receiving

CA(+)-membrane mixtures (1:10), but animals of the control group had a
mean maximum of 240 on day 14. Animals receiving a five-fold increase
of antigen in buffer showed no response to secondary injections.
Substitution of membranes for buffer, in this instance, did not restore
the ability of the animals to respond to the CA(+).

M_. arthritidis

membranes seemed to affect immune responses to the CA(-) and to the
CA(+) in a different manner.

The lower HA titers in rabbits immunized

with the CA(+), however, is a commonly observed phenomenon (Whang
and Neter, 1967, 1968).
Primary MI antibody response to M. arthritidis membranes. The
different responses obtained in rabbits injected simultaneously with
either CA(-)- or CA(+)-membrane mixtures led to speculation that
immune responses to _M. arthritidis antigens might also be altered in
the presence of the CA(+).

MI antibody titers were determined on sera

obtained from four animals of each test group and two animals of each
control group prior to immunization and at 3, 7, 14, and 21 days after
the final primary immunizing injections.

Mixtures of the CA(+) and

M. arthritidis membranes were associated with a diminished yield of
MI antibodies in all animals (Table 19).

The CA(+)-membrane mixtures

(1:10) produced a mean maximum titer of

28 on day 21, whereas equal

Table 18.

Comparison of the Effect of M_. arthritidis Membranes (1:10) and (1:1) on Secondary
Hemagglutinin Responses of Rabbits to CA(+)

Immunizing Materials

Animal No.
0

CA(+)+ buffer (1:10)

23
24
Mean

CA(+)+M_. arthritidis
membranes (1:10) .

25
26

Mean
CA(+)+ buffer (1:1)

27
28

Mean
CA(+)+M_. arthritidis
membranes (1:1)

33

34
Mean

Hemagglutinin Titer on Day
7

14

< 10
< 10
< 10

80
320
200

160
320
240

< 10
< 10
< 10

<10
<10
<10

<10
<10
<10

< 10
< 10
< 10

<10
<10
<10

<•10
<10
<10

<10
<10
<10

<10

<10
10
M0

20

M5

00
00

Table 19.

Metabolism-Inhibiting Antibody Titers in Rabbits Following Primary Immunization With
CA (+)-M. arthritidis Membranes (1:10) and (1:1)

Immunizing Materials

CA(+)+ buffer (1:10)

CA(+)+M_. arthritidis
membranes (1:10)

Animal No.

24

<10
<10

< 10
< 10

<10
<10

< 10
< 10

<10
<10

Mean

<10

< 10

<10

< 10

<10

25
26
27
28

<10
<10
<10
<10
<10

<10
<10
< 10
^ 13

<10
<10
<10
<10
<10

<
<
<
<
<

10
10
10
10
10

<10
<10
<10
^28

30

<10
<10

<10
<10

<10
<10

< 10
< 10

<10
<10

Mean

<10

< 10

<10

<10

<10

31
32
33
34
Mean

<10
<10
<10
<10
<10

<10
160
<10
160
^85

<10
160
20
160
^88

20
320
80
80
250

20
160
40
80
150

23

Mean
CA(+)+ buffer (1:1)

CA(+)+M_. arthritidis
membranes (1:1)

Metabolism-Inhibiting Antibody Titer on Day
14
21
7
0
3

29

20

80

CO
CO
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quantities of the CA(+)-membranes yielded a mean maximum titer of 250
on day 14.
Secondary MI antibody response to M. arthritidis membranes.
In order to assess the secondary immune response to fd. arthritidis
membranes injected simultaneously with CA(+), two animals from each
test and each control group were inoculated with booster injections of
the immunizing agents after a two-month rest period during which the
MI antibody titers returned to pre-immunization levels.

Serum samples

were obtained prior to administration of the booster doses and 7 and 14
days later.

Both rabbits receiving the CA(+)-membrane mixtures (1:10)

and one rabbit receiving the CA(+)-membrane mixtures (1:1) responded
poorly to M_. arthritidis membrane antigens (Table 20). A maximum
mean MI antibody titer of only 80 occurred on day 14 for animals
receiving the larger quantity of membranes.

Table 20.

Metabolism-Inhibiting Antibody Titers in Rabbits Following Secondary Immunization with
CA (+)-M. arthritidis Membranes (1:10) and (1:1)

Immunizing Materials

CA(+)+ buffer (1:10)]

CA(+)+ M. arthritidis
membranes (1:10)

CA(+)+ buffer (1:1)

CA(+)+M_. arthritidis
membranes (1:1)

Animal No.

Metabolism-Inhibiting Antibody Titer on Day
14
7
0

24

<10
<10

< 10
< 10

< 10
< 10

Mean

<10

< 10

< 10

25
26

<10
<10

< 10
80

80
80

Mean

<10

^45

80

29
30

<10
<10

< 10
< 10

< 10
< 10

Mean

<10

< 10

< 10

31
32

‘:10
<10

20
80

2560

Mean

<10

50

1300

23

40

CO
I—1

DISCUSSION

This study demonstrated that oleic acid increased arthritogenic
properties of a passaged culture of _M. arthritidis (158), but had little
or no effect on a laboratory-maintained culture of the same strain.
Although the incidence of arthritis did not vary significantly in groups
of rats receiving M_. arthritidis under different growth conditions.
mean arthritis scores were significantly higher for animals receiving
the passaged mycoplasmas grown in the oleic acid-enriched broth. A
mean arthritis score of 34.9 was obtained on day eight as compared with
a mean score of 8. 9 on day six for animals inoculated with ceils grown
without the oleic acid supplement.

The mean arthritis score of animals

receiving the laboratory-maintained culture was only slightly higher
when organisms were grown in the presence of oleic acid.

Several

investigators have been able to induce more severe arthritis in rats
after passage (Collier, 1939; Klieneberger, 1939; Parkes and Wrigley,
1951; Preston, 1942; Warren, 1942).

In the present study, however,

differences between mean maximum arthritis scores for passaged
organisms grown without supplemental oleic acid and laboratorymaintained organisms grown in the presence or absence of added oleic
acid were minimal.

Only the time of the maximum scores was delayed

with laboratory-maintained organisms.
92

Golightly-Rowland et al. (1970)
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reported a passaged culture of 1VL arthritidis strain 158 to have only
a slightly lower

than unpassaged organisms. Arthritis scores

and numbers of limbs involved were, however, higher with passaged
organisms.
The enhanced virulence of the passaged culture but not of the
laboratory-maintained culture of IVL arthritidis by the oleic acid supple
ment indicates that factors other than those supplied by the cultural
environment also play a significant role in virulence.

It is possible

that the membrane composition of passaged and laboratory-maintained
cultures of id. arthritidis could vary, and that oleic acid in increased
quantities could, therefore, affect the integrity of membranes in a
different manner.

There is no information relating the morphology of

M. arthritidis directly to the arthritogenic properties of the organism,
but it appears likely that pleomorphism could affect exposure of anti
genic sites and the course of the disease in the host.
The greater cell yields of M_. arthritidis grown with added oleic
acid may result from stimulation of growth and increased viability of
the cell population.

Growth of laboratory strains of M_. pneumoniae

were demonstrated by Kraybill, Allen, and Crawford (1969) to be
improved by the inclusion of Dubos oleic albumin complex in myco
plasmal agar.

Those same investigators reported that attempted

isolations of M_. pneumoniae from throat cultures on medium supplemented
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with Dubos oleic albumin complex were twice as likely to be successful
as attempts on conventional mycoplasmal agar.
Lack of cell walls makes mycoplasmas particularly susceptible
to effects of environmental pressures which can destroy viability.

It is

impossible to equate the in vivo milieu of mycoplasmas with any
artificial environment and, likewise, difficult to relate viability of
populations in vitro to survival in the host.

However, the minimum

reductions in CPU in oleic acid-enriched broths incubated longer than
48 hr would seem to suggest that the presence of oleic acid in the
growth media may increase cell yields and prolong viability of cell
populations.
The observed propensity for arthritic hind limb involvement in
experimentally induced arthritis has been reported by many investigators
(Woglom and Warren, 1938; Ward and Jones, 1962; Cole et al. , 1969b;
Miller et al. , 1970).

Multiple joint involvement was common in the

current study, but metacarpal, metatarsal, and ankle joints were most
frequently involved.

The predilection of some microorganisms for

particular sites, such as synovial tissue, is not wTell understood.

Many

microorganisms injected iv apparently selectively propagate and persist
primarily in the synovium.

The inflammatory process and the tissue

breakdown which ensues may be associated with release of host-cell
enzymes which, in turn, may alter host protein, thereby eliciting
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antibody production and extended inflammation (Weissman, Spilberg,
and Krauskauer, 1969).

Specific antigens capable of initiating an

auto-immune response have not been identified.

Moreover, even their

existence need not contribute to infectious arthritis.

Whatever the

specific initiating event or insult, the joint apparently provides a
unique milieu required for the self-perpetuating events which lead to
the classical symptoms of edema, redness, tenderness, and eventual
deformity.
In the present experiment, animals injected with passaged
M. arthritidis grown in the presence or absence of oleic acid as a
supplement exhibited no distinct histological differences in the devel
opment, course, or resolution of the inflammatory process.

The

suppurative response and the subsequent reconstruction in arthritic
joints were consistent with that observed in Mycoplasma-induced
polyarthritis in rats by Ward and Jones (1962).

The inflammatory changes

and the sequence of events produced by M_. arthritidis are non-specific
and can be produced by a variety of etiological agents including
irritants (Selye and Jasmin, 1956), mycobacterial adjuvants (Pearson
and Wood, 1959), microorganisms (Preston, 1942), and hormones (Selye
et al. , 1944).
Most of the infiltrating cells in joint spaces of animals with
macroscopic lesions were polymorphonuclear leukocytes.

This is
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consistent with the type of infiltration observed by others in experi
mental models of Mycoplasma-induced arthritis (Ward and Jones, 1962;
Cole et al • / 1971a).

Plasma cells and lymphocytes have been reported

to predominate in the exudates of human rheumatoid disease and in
periarthritis induced in rats by 6-sulfanilamidoindazole (Miller et al. ,
1970).

The synovitis, the focal infiltration of exudate into muscle

tissue, and the joint deformities are characteristic, however, of both
human rheumatoid arthritis and of Mycoplasma-induced arthritis in the
rat.

The similarities in the disease process make animal models useful

in the study of various host or environmental factors which can modify
the severity or the course of mycoplasmal arthritis.

The increasing

number of isolations of Mycoplasma species from joint fluid of rheuma
toid patients (Bartholomew, 1965; Williams et al. , 1970) presents at
least circumstantial evidence for their involvement in human disease.
It would appear both from the current study and earlier studies
by Cole et al. (1969) that early rises in CF titer are characteristic of
the rat.

In the present study, there was no significant difference in CF

antibody titers between animals injected with passaged M_. arthritidis
grown with or without the oleic acid supplement in spite of a significant
difference in arthritis scores between the two groups. Other investi
gators reported little or no difference in the CF antibody response to
virulent and avirulent strains of the same organism (Golightly-Rowland
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et al • / 1970).

Instead, the severity of arthritis and levels of CF

antibody were observed by Cole et al. (1969) to be proportional to the
number of organisms in the inocula.

The lack of a demonstrated

relationship between the levels of CF antibodies and the arthritogenic
properties of I\d. arthritidis suggests that determinants for CF antibody
and for arthritogenic properties are not identical.
In the current study, no MI antibody was detectable in rats
injected with passaged M_. arthritidis grown with or without an enrich
ment of oleic acid.

The complete lack of any MI antibody response

suggests that still other factors may be involved in the production of
MI antibody.

The inability of the rodent host to produce MI antibody

may explain, at least in part, the disease-producing capacity of the
organism in the rat.

The observed interference with the CA(-) or the

CA(+) hemagglutinin production in a non-rodent host by _M. arthritidis
membranes leads to the speculation that membrane components could
also affect the antibody responses in the infected rodent host.

The

numbers of mycoplasmas needed to induce arthritis in rats is substantial,
ranging from 10u to 10 9 cells.

Further studies are needed to determine

the extent, the nature, and the mechanism of the immunosuppressive
effect of Id. arthritidis membrane components.
Several mechanisms may be involved in the pathogenesis of
Mycoplasma-induced arthritis in rats.

The immunogenic and arthrito

genic properties of M_. arthritidis may be only partially related.

The
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manifestations of the disease process are complex and are conditioned
both by the immune responses of the host and by the nature of the
infecting agent.

The present study demonstrated that the nature of

M. arthritidis may be artificially altered to promote a more severe
infection without affecting CF or MI antibody syntehsis.

This observa

tion indicates the importance of environmentally modified organisms in
disease.
Pre-incubated mixtures of membranes isolated from passaged
M. arthritidis (158) and the CA(-) from E. coli (014) suppressed the HA
response of rabbits against CA(-).

Even increasing the amount of the

antigen five-fold did not overcome the immunosuppressive effect of
membranes when the antigen and the membranes were mixed in 1:1
proportions.

The interference in the secondary response to the CA(-) by

mycoplasmal membranes paralleled the observed immunosuppressive
effect of the primary response. When the ratio of the CA(-) to the
membranes was 1:10, inhibition of the secondary response was greater
than with the 1:1 mixtures, thereby indicating a dependence on propor
tion.

The extent of inhibition by cardiolipin was also demonstrated by

Whang and Neter (1968) to be related to antigen dose.
All animals injected simultaneously with the CA(-)-membrane
mixtures produced MI antibodies against _M. arthritidis both after
primary immunization and in response to the booster injections.

Com

parisons of the FLA and the MI antibody responses revealed consistently
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higher MI antibody titers (Figures 18, 19, 20, and 21).

The specificity

of the MI techniques has been attributed to the measurement of surface
antigens on the cell envelope (Purcell et al • / 1966).

The CA(-) did

not seem, therefore, to mask the antigenic determinants for MI anti
body in the CA(-)-membrane mixtures.

Competitive inhibition could

account for the lower HA titers if antibody-producing cells had different
affinities for the immunogenic determinants of the CA(-) and of the
mycoplasmal membranes.
The effect of pre-incubated mixtures of M_. arthritidis (158)
membranes and the CA(+) from S_. aureus on the primary HA antibody
response of rabbits to the CA(+) also depended on membrane concen
trations.

The lack of significant interference with antibody synthesis

in the primary response using high concentrations of membranes may
reflect differences in CA(-) and CA(+) determinants.

Restoration of

immunogenicity by the 1:1 CA(+)-membrane mixtures may have been
associated with less competition for sites on antibody-producing cells.
The secondary responses to antigen-buffer mixtures (1:10)
were typically of greater magnitude than those exhibited after primary
immunization.

The lack of demonstrable antibodies for animals

receiving membranes and antigen in a 1:10 proportion suggests that in
at least two animals priming had not occurred. The secondary responses
of animals receiving five-fold increases in antigen with or without
membranes remained effectively paralyzed.

Figure 18.

Primary CA(-) Hemagglutinin ( @--------- # ) and Metabolism-Inhibiting Antibody
O ) Responses in Rabbits Receiving CA(-)-M. arthritidis Membranes (1:10)
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Figure 19.

■A ) and Metabolism-Inhibiting Antibody
Primary CA.(-) Hemagglutinin ( A
(A
■A ) Responses in Rabbits Receiving CA(-)-M. arthritidis Membranes (1:1)
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Figure 20.

Secondary CA(-) Hemagglutinin ( ©■
<1 ) and Metabolism-Inhibiting Antibody
■Q ) Responses in Rabbits Receiving CA(-)-M. arthritidis Membranes (1:10)
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Figure 21.

Secondary CA(-)- Hemagglutinin ( A■A ) and Metabolism-Inhibiting Antibody
■A ) Responses in Rabbits Receiving CA(-)-M. arthritidis Membranes (1:1)
(A

107

2560 n
O
Z

1280-

■A

CD

X

21

640-

i

2

co

6

320-

CQ CO
<
h— LU
UJ h-

160“
Q >T
Q

Z

<o
DO

Z h=

80-

^Z
£: <;
3

__ i

o
o
<
2

40“

20-

UJ

X
I
<

u

10<10
0

T

1

7
DAYS

14

108
It could be expected that various components of M_. arthritidis
membranes might affect antibody synthesis to bacterial antigens in
different ways since the physicochemical characteristics of the CA(-)
and of the CA(+) are not the same.

Hammarstrom (1971) reported the

immunogenic portion of CA of E_. coli (014) to be a part of the core
structure.

Chorpenning and Dodd (1966) postulated that two different

CA(+) antigens occur, at least one of which is present in many foods.
An antigen from streptococci studied by Moskowitz (1966) and Jackson
and Moskowitz (1966) revealed the presence of a polymer of glycero
phosphate and d-alanine which reacted with antibodies.

The possibility

that different mechanisms may be involved in the immunosuppression
of antigenic response to specific antigens must be considered.

Further

studies are needed to identify the specific determinants of the CA(-)
and the CA (+).
A comparison of the HA and the MI antibody responses induced
by CA(+)-membrane mixtures revealed that neither the primary nor the
secondary responses were associated with high HA or MI antibody
titers (Figures 22, 23, 24, and 25).

With the CA(+)-membrane mixtures.

the primary MI antibody titers were lower than those obtained with the
CA(-)-membrane mixtures.

The low MI titers may indicate that

responses of animals to stimulation by immunogenic determinants for MI
antibodies are subject to the effect of competition by the alcohol
soluble CA(+).

Figure 22.

■O ) and Metabolism-Inhibiting Antibody
Primary CA(+) Hemagglutinin ( ©•
O ) Responses in Rabbits Receiving CA(+)-M. arthritidis Membranes (1:10)
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Figure 23.

Primary CA(+) Hemagglutinin ( A•A ) and Metabolism-Inhibiting Antibody
( A■A ) Responses in Rabbits Receiving CA(+)-M. arthritidis Membranes (1:1)
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Figure 24.

•O ) and Metabolism-Inhibiting Antibody
Secondary CA(+) Hemagglutinin ( ©■
O ) Responses in Rabbits Receiving CA(+)-M. arthritidis Membranes (1:10)
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Figure 25.

Secondary CA(+) Hemagglutinin ( A•A ) and Metabolism-Inhibiting Antibody
■A ) Responses in Rabbits Receiving CA(+)-M. arthritidis Membranes (1:1)
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The level of antibody response is not necessarily an expression
of the magnitude of an antigenic stimulus (Adler, 1957; Chen et al. ,
1959). Antigens producing low levels of antibody can act as effective
competitors if animals are injected simultaneously with heterologous
antigen (Abramoff and Wolfe, 1956).

The growth of mycoplasmas in a

rabbit-infusion medium and the propensity of mycoplasmal membranes
to incorporate components of the culture medium could provide the
opportunity for M_. arthritidis to act as a vehicle for heterologous
antigens or as an immunosuppressive agent.
Competitive inhibition by membrane components may explain,
in part, the failure to demonstrate MI antibodies in M_. arthritidis induced arthritis in rats and the paucity of such antibodies in sera of
patients from whose joint M_. arthritidis or M_. hominis has been
isolated.

The current study suggests not only that the immunosuppres

sive effects are not host specific but that they may be effective in very
low concentrations.

Infection does not appear to be a prerequisite for

immunosuppression.

Furthermore, the effect could be rather widespread

since responses to both the CA(-) and the CA(+) were inhibited.
Further studies are required to find out if heterogenetic antigens or
membrane-associated immunosuppressive agents are operative in
either the CA(-) or the CA(+)-M. arthritidis membrane system.

If

mycoplasmas can serve as vehicles for immunosuppressive agents or
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can compete for antigenic sites in vivo, some insight may be gained
not only into the pathogenesis of M_. arthritidis-induced infections.
but also into a possible role for cell-wall deficient organisms in
altering immune responses.

SUMMARY

The virulence of animal-passaged M_. arthritidis (158) for rats
was demonstrated to be enhanced by growth in oleic acid-enriched
broth.

The virulence of a laboratory-maintained culture of the same

strain was unaffected by similar growth conditions.

No differences

either in the immune response as measured by CF antibodies or in the
histogenesis of the disease were detected when rats were injected
with animal-passaged M_. arthritidis grown either in the presence or in
the absence of oleic acid. All tests for MI antibody in the rat were
negative.
& Mycoplasma-associated immunosuppression of the primary
and of the secondary HA responses to CA(-) was demonstrated in the
rabbit when pre-incubated mixtures of CA(-) and 1VL arthritidis
membranes were injected iv. A similar immunosuppression was
demonstrated only for the secondary HA response to CA(+) when pre
incubated mixtures of CA(+) and M. arthritidis membranes were
employed as immunizing materials.

Mixtures containing CA(+)

appeared to interfere with MI antibody production in the rabbit.
The findings suggest 1) that oleic acid may play a role in
the virulence of animal-passaged M_. arthritidis in the rat, 2) that
MI antibody synthesis may be subject to competitive inhibition by
119

120
CA(+) in the rabbit, and 3) that the immunosuppressive effect of
M. arthritidis is associated with membrane components and is not
limited to the host in which arthritogenic properties are manifested.
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abstract

The virulence of animal-passaged Mycoplasma arthritidis (158)
was demonstrated to be enhanced in rats by growth in oleic acid-enriched
broth.

The virulence of a laboratory-maintained culture of the same

strain was unaffected by similar growth conditions.

No differences

either in the immune response as measured by complement-fixing (CF)
antibodies or in the histogenesis of the disease were detected when
rats were injected with animal-passaged M_. arthritidis grown either in
the presence or in the absence of oleic acid. All tests for metabolisminhibiting (MI) antibodies in the rat were negative.
A Mycoplasma-associated immunosuppression of the primary
and of the secondary hemagglutinin (HA) response to a common Gram
negative antigen (CA-) of Escherichia coli (014) was demonstrated in
the rabbit when pre-incubated mixtures of CA(-) and _M. arthritidis
membranes were injected iv. A similar immunosuppression was demon
strated only for the secondary HA response to a common Gram positive
antigen (CA+) of Staphylococcus aureus when pre-incubated mixtures
of CA(+) and M_. arthritidis membranes were employed as immunizing
materials.

Mixtures containing CA(+) appeared to interfere with MI

antibody production in the rabbit.
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The findings suggest 1) that oleic acid may play a role in the
virulence of animal-passaged M_. arthritidis in the rat# 2) that MI
antibody synthesis may be subject to competitive inhibition by (CA+)
in the rabbit, and 3) that the immunosuppressive effect of M_. arthritidis
is associated with membrane components and is not limited to the host
in which arthritogenic properties are manifested.
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